InsidersTradesSigma
Follow the Medivir AB share price and the full management transaction log of the company, a listed equity based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Medivir AB has logged 4 insider filings. Market capitalisation: €1.1bn. The latest transaction was reported on 19 June 2026 (Purchase). Among the most active insiders: Magnus Christensen. Every trade is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
Medivir AB is a Swedish pharmaceutical company focused on the development of antiviral treatments. It is listed on the Stockholm Stock Exchange.